UA86986C2 - Композиция очищенного арабиногалактан-протеина (agp) - Google Patents

Композиция очищенного арабиногалактан-протеина (agp)

Info

Publication number
UA86986C2
UA86986C2 UAA200701654A UAA200701654A UA86986C2 UA 86986 C2 UA86986 C2 UA 86986C2 UA A200701654 A UAA200701654 A UA A200701654A UA A200701654 A UAA200701654 A UA A200701654A UA 86986 C2 UA86986 C2 UA 86986C2
Authority
UA
Ukraine
Prior art keywords
agp
protein
composition
extract
aqueous
Prior art date
Application number
UAA200701654A
Other languages
English (en)
Ukrainian (uk)
Inventor
Судершан Кумар Арора
Вандита Шривастава
Самир Шанкар Валундж
Original Assignee
Люпин Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Люпин Лимитед filed Critical Люпин Лимитед
Publication of UA86986C2 publication Critical patent/UA86986C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
UAA200701654A 2004-09-01 2005-04-26 Композиция очищенного арабиногалактан-протеина (agp) UA86986C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/931,814 US7601368B2 (en) 2004-09-01 2004-09-01 Purified Arabinogalactan-Protein (AGP) composition useful in the treatment psoriasis and other disorders

Publications (1)

Publication Number Publication Date
UA86986C2 true UA86986C2 (ru) 2009-06-10

Family

ID=35943518

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200701654A UA86986C2 (ru) 2004-09-01 2005-04-26 Композиция очищенного арабиногалактан-протеина (agp)

Country Status (19)

Country Link
US (4) US7601368B2 (ru)
EP (1) EP1789439B1 (ru)
JP (1) JP2008511613A (ru)
KR (1) KR20070059062A (ru)
CN (1) CN101044161A (ru)
AP (1) AP2007003929A0 (ru)
AT (1) ATE452142T1 (ru)
AU (1) AU2005278780A1 (ru)
BR (1) BRPI0514347A (ru)
CA (1) CA2577134A1 (ru)
DE (1) DE602005018375D1 (ru)
EA (1) EA012208B1 (ru)
IL (1) IL181230A0 (ru)
MX (1) MX2007002428A (ru)
NO (1) NO20071120L (ru)
TN (1) TNSN07079A1 (ru)
UA (1) UA86986C2 (ru)
WO (1) WO2006025068A1 (ru)
ZA (1) ZA200701311B (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2399993T3 (es) 2007-03-02 2013-04-04 Protectimmun Gmbh Composición farmacéutica para la protección frente a alergias y enfermedades inflamatorias
FR2938192B1 (fr) 2008-11-07 2012-08-24 Expanscience Lab Nouvel actif anti-vergetures et compositions le comprenant
WO2010020379A1 (en) * 2008-08-16 2010-02-25 Protectimmun Gmbh Composition for prevention and treatment of allergic and/or inflammatory diseases
AU2011249145B2 (en) 2010-05-05 2013-05-23 Comvita New Zealand Limited Immunostimulatory compositions and methods of use thereof
FR2975004B1 (fr) * 2011-05-13 2013-06-28 Expanscience Lab Nouvel actif anti-rougeurs et compositions cosmetiques le comprenant
ITMI20112216A1 (it) 2011-12-05 2013-06-06 Fond Salvatore Maugeri Clinic A Del Lavoro E Composizione comprendente un estratto di chelidonium majus e copaiba e il suo impiego per il trattamento di disfunzioni cutanee
WO2014190398A1 (en) * 2013-05-31 2014-12-04 The University Of Melbourne Inhibition of amyloid fibril formation
US11179407B2 (en) 2015-12-01 2021-11-23 Forschungszentrum Borstel Leibniz-Zentrum Für Medizin Und Biowissenshaften Method for synthetically producing arabinogalactan compounds derived from plants and uses of said compounds for the prophylaxis of allergic reactions
EP3176175B1 (en) 2015-12-01 2020-07-01 Ruhr-Universität Bochum Method for synthetically producing arabinogalactan compounds derived from plants and uses of said compounds for the prophylaxis of allergic reactions
US10973858B2 (en) 2016-02-12 2021-04-13 Laimu Corporation Nerve growth promoter and method for producing same, internal preparation, medium additive, cell dilution additive, medium, cell dilution, antioxidant and method for producing same, external preparation, and wound treatment agent and method for producing same
JP6230638B2 (ja) * 2016-02-12 2017-11-15 株式会社らいむ 神経伸長促進剤、内服剤、培地用添加剤、細胞希釈液用添加剤、培地および細胞希釈液

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818533A (en) * 1985-07-09 1989-04-04 Vipont Pharmaceutical, Inc. Production of high purity alkaloids
US5494671A (en) * 1990-08-27 1996-02-27 The United States Of America As Represented By The Department Of Health And Human Services C-terminally truncated dengue and Japanese encephalitis virus envelope proteins
JP3177642B2 (ja) * 1991-09-10 2001-06-18 ライオン株式会社 抗男性ホルモン剤
WO2001000682A1 (en) 1999-06-30 2001-01-04 Pharmagenesis, Inc. Hematopoietic arabinogalactan composition
EP1467745A2 (en) * 2002-01-10 2004-10-20 Lupin Limited Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders

Also Published As

Publication number Publication date
NO20071120L (no) 2007-05-14
JP2008511613A (ja) 2008-04-17
AU2005278780A1 (en) 2006-03-09
EP1789439A1 (en) 2007-05-30
AP2007003929A0 (en) 2007-02-28
US20090270330A1 (en) 2009-10-29
BRPI0514347A (pt) 2008-06-10
ZA200701311B (en) 2009-08-26
CN101044161A (zh) 2007-09-26
WO2006025068A8 (en) 2006-04-20
US20060045930A1 (en) 2006-03-02
MX2007002428A (es) 2007-05-11
US20100330650A1 (en) 2010-12-30
US7601368B2 (en) 2009-10-13
EA012208B1 (ru) 2009-08-28
CA2577134A1 (en) 2006-03-09
EA200700532A1 (ru) 2007-08-31
KR20070059062A (ko) 2007-06-11
TNSN07079A1 (en) 2008-06-02
US20090264341A1 (en) 2009-10-22
DE602005018375D1 (de) 2010-01-28
ATE452142T1 (de) 2010-01-15
WO2006025068A1 (en) 2006-03-09
EP1789439B1 (en) 2009-12-16
IL181230A0 (en) 2007-07-04

Similar Documents

Publication Publication Date Title
UA86986C2 (ru) Композиция очищенного арабиногалактан-протеина (agp)
US5854404A (en) Antitumor substance extracted from grifola
CN101830906B (zh) 一种高纯度光甘草定的分离纯化方法
JP2006516962A5 (ru)
CA2412600A1 (en) Potent immunostimulatory polysaccharides extracted from microalgae
CN103432193A (zh) 一种微波辅助双水相提取分离葛根总黄酮的方法
CN110845634B (zh) 油茶枯饼中的多糖提取物及其提取方法
WO2015103974A1 (zh) 麦角硫因的提取及纯化方法
Guinea et al. Biologically active triterpene saponins from Bupleurum fruticosum
CN101708195B (zh) 银杏提取物的生产工艺
JP2011026525A (ja) β−グルカンを主体とする多糖類の抽出方法
CN111978424A (zh) 一种一步纯化铁皮石斛水溶性多糖的方法
Holland et al. Preparation of (R)-sulforaphane by biotransformation using Helminthosporium species NRRL 4671
RU2388819C2 (ru) Способ получения пероксидазы хрена
CN112321742A (zh) 一种云芝胞外多糖的分离纯化及其结构表征
CN102618514B (zh) 超滤提取辣根过氧化物酶的方法
IE39246B1 (en) Process for preparing a purified extract of quillata bark
JP3925828B2 (ja) アクテオシドの抽出法
CN102600215A (zh) 一种提取骆驼蓬生物碱的方法
CN104435015A (zh) 一种高品质银杏黄酮提取工艺
CN105193880A (zh) 一种软枣猕猴桃黄酮的提取方法
CN102805755A (zh) 一种高品质银杏黄酮的制备方法
CN106148449B (zh) 一种淫羊藿次苷i的制备方法
CN110511252A (zh) 一种微波-分子印迹聚合物联用提取纯化苹果多酚的方法
CN114276468B (zh) 一种天然成分和在美白并增加皮肤弹性中的应用